European equities traded in the US as American depositary receipts were trending slightly higher late Friday morning, edging up 0.11% to 1,880.31 on the S&P Europe Select ADR Index, which has surged 3% for the week so far.
From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and semiconductor company Sequans Communications (SQNS), which climbed 8.1% and 2.7% respectively. They were followed by furniture maker Natuzzi (NTZ) and telecommunications company Ericsson (ERIC), which increased 3.1% and 1.9% respectively.
The decliners from continental Europe were led by oil and gas company Eni (E) and lender Banco Santander (SAN), which dropped 2.3% and 1.6% respectively. They were followed by biopharmaceutical company Grifols (GRFS) and lender Banco Bilbao Vizcaya Argentaria (BBVA), which lost 1.4% and 0.9% respectively.
The gainers from the UK were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Mereo BioPharma (MREO), which advanced 73% and 6.7% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Bicycle Therapeutics (BCYC), which were up 3.6% and 1.1% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Trinity Biotech (TRIB), which fell 3.1% and 2.4% respectively. They were followed by insurance company Prudential (PUK) and pharmaceutical company Silence Therapeutics (SLN), which were down 1.7% and 0.2% respectively.
Comments